Efficacy and safety of CGP 56697 (artemether and benflumetol) compared with chloroquine to treat acute falciparum malaria in Tanzanian children aged 1-5 years.
about
Artemether-lumefantrine (six-dose regimen) for treating uncomplicated falciparum malariaArtemether-lumefantrine (four-dose regimen) for treating uncomplicated falciparum malariaTransmission-blocking activities of quinine, primaquine, and artesunateReduction of malaria transmission to Anopheles mosquitoes with a six-dose regimen of co-artemetherA pilot randomised trial of induced blood-stage Plasmodium falciparum infections in healthy volunteers for testing efficacy of new antimalarial drugsChild mortality patterns in rural Tanzania: an observational study on the impact of malaria control interventions.Age interactions in the development of naturally acquired immunity to Plasmodium falciparum and its clinical presentation.Therapeutic efficacy of Artemether/Lumefantrine (Coartem(R)) against Plasmodium falciparum in Kersa, South West EthiopiaArtemether-lumefantrine for the treatment of multidrug-resistant falciparum malaria.In vitro activities of benflumetol against 158 Senegalese isolates of Plasmodium falciparum in comparison with those of standard antimalarial drugs.Therapeutic efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in North-Eastern TanzaniaPopulation pharmacokinetics and pharmacodynamics of artemether and lumefantrine during combination treatment in children with uncomplicated falciparum malaria in Tanzania.Comparative clinical trial of two-fixed combinations dihydroartemisinin-napthoquine-trimethoprim (DNP) and artemether-lumefantrine (Coartem/Riamet) in the treatment of acute uncomplicated falciparum malaria in Thailand.Malaria treatment failures after artemisinin-based therapy in three expatriates: could improved manufacturer information help to decrease the risk of treatment failure?History, dynamics, and public health importance of malaria parasite resistance.The effect of dose on the antimalarial efficacy of artemether-lumefantrine: a systematic review and pooled analysis of individual patient data.Artemether-lumefantrine for uncomplicated malaria: a systematic review.Coartemether (artemether and lumefantrine): an oral antimalarial drug.Spatial and space-time clustering of mortality due to malaria in rural Tanzania: evidence from Ifakara and Rufiji Health and Demographic Surveillance System sites.Efficacy and safety of artemisinin-based antimalarial in the treatment of uncomplicated malaria in children in southern TanzaniaFrom chloroquine to artemether-lumefantrine: the process of drug policy change in Zambia.Exploration of in vivo efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria in under fives in Tabora region, TanzaniaAssessment of safety of the major antimalarial drugs.The content of African diets is adequate to achieve optimal efficacy with fixed-dose artemether-lumefantrine: a review of the evidence.Evaluation of the efficacy and safety of artemether-lumefantrine in the treatment of acute uncomplicated Plasmodium falciparum malaria in Nigerian infants and children.Impact on malaria morbidity of a programme supplying insecticide treated nets in children aged under 2 years in Tanzania: community cross sectional study.Artemisinin-based combination therapy for uncomplicated malaria in sub-Saharan Africa: the efficacy, safety, resistance and policy implementation since Abuja 2000.Plasmodium falciparum gametocytes: with a view to a kill.Fighting fire with fire: mass antimalarial drug administrations in an era of antimalarial resistance.The Relative Effects of Artemether-lumefantrine and Non-artemisinin Antimalarials on Gametocyte Carriage and Transmission of Plasmodium falciparum: A Systematic Review and Meta-analysis.Plasmodium falciparum msp1, msp2 and glurp allele frequency and diversity in sub-Saharan Africa.Distinction of recrudescences from new infections by PCR-RFLP analysis in a comparative trial of CGP 56 697 and chloroquine in Tanzanian children.Desbutyl-benflumetol, a novel antimalarial compound: in vitro activity in fresh isolates of Plasmodium falciparum from Thailand.The straw that breaks the camel's back. Redirecting health-seeking behavior studies on malaria and vulnerability.Dynamics of multiple Plasmodium falciparum infections in infants in a highly endemic area of Tanzania.Age dependence of the multiplicity of Plasmodium falciparum infections and of other malariological indices in an area of high endemicity.The epidemiology of multiple Plasmodium falciparum infections. 1. General introduction.Stability-indicating HPLC-DAD/UV-ESI/MS impurity profiling of the anti-malarial drug lumefantrine.An estimation of the entomological inoculation rate for Ifakara: a semi-urban area in a region of intense malaria transmission in Tanzania.The changing epidemiology of malaria in Ifakara Town, southern Tanzania.
P2860
Q24245437-8524DE70-A57B-41C6-8B02-80B8A1DDCBEAQ24246332-90A6B2C3-B4E8-4633-BE8E-C99EB5BA4E98Q24548262-B584DA86-AEDD-459F-A234-E3EFE19FB9FBQ24792020-F6BF8D15-EA17-4121-8771-89B859FDD2CCQ28476638-CCEE4D51-3D55-437B-A62C-B0B8630CF914Q30392139-96836AD3-13F8-4D11-B72A-D1491E7BA23FQ33293164-24E413B3-E393-47E8-B57B-A56E07463FF0Q33895092-E165FD1A-BEB0-4D26-B2C6-E61E92C5A3A6Q33929311-3CF907CB-F4DA-48B8-BB16-7DB213612F7FQ33976132-7C51809B-CA93-4E78-BF5C-C410B7DB3DBEQ34253706-9FC94AB2-18EE-4753-82CE-88EA599837C2Q34290067-CAEB90D1-48AB-4909-B5DE-CA2AC0078F83Q35069115-2F0C4116-C730-4150-A6E6-3AE9E191F832Q35079965-DF29704A-0EA4-458F-9702-890155A03616Q35545447-FC949AAE-166F-4EFD-AE74-6A936F0FF384Q35580908-B83FB0AE-86D1-4B2E-BEB5-54A4F4754AECQ35709551-CF3EFFB6-090C-42A7-B615-812F892DCC7CQ35917361-478B7AE7-96A0-4441-8B3F-760ED38AF61FQ36094670-9685DAB1-BA34-4B3A-8127-66AD892478C0Q36372819-AAE40A00-8756-4D77-A39C-933163582ECFQ36471166-CF6D44C4-8DE6-4840-A94D-3F741FEB082CQ36797637-F554D989-CB83-455E-AAEC-B21C5917DE94Q36945007-C2CA555B-1270-4381-B41A-D8704FEAB23DQ37032498-7B2168FA-0208-4391-84D9-F9579AF93A88Q37037149-0554CACF-EC82-488F-9799-600D39B68082Q37133983-F987BF47-B104-4EF9-AFD3-3F76834A4AD9Q37171336-8FDF59A6-88B6-46EC-8111-0344892BE25FQ38129536-287D8954-941F-4ED4-B8DF-E363E35A2214Q38399949-A8AD7647-3589-4407-A7C6-E7F89DE69C5DQ38840716-A73F9469-3D13-4992-B0AB-21481651617AQ38870446-B1EABB5C-F309-4372-AEDE-762A5BF49D99Q39095061-191FCC8C-AA63-4518-8DA0-C5935E0C38FBQ39307614-76C547EF-B59F-494C-96C3-C78283C3376AQ39396439-9607267B-7845-462B-90E0-088036D00F0BQ39473605-B90034F2-FDDD-4271-B8BF-4181B0E2222FQ39473612-44E482DC-D9C0-4D6A-9BBE-9D874D186264Q39510466-A1577AD0-E100-4C02-B8A7-B5385B790D62Q39557345-FCC2A386-1DB3-4299-A9D9-2E5DFEF972CDQ39658820-CC401D5A-704F-48EB-8EF6-1C476B2AE7EFQ39674032-F4BBEE76-5470-468E-A1AF-0A4D09EBAB3B
P2860
Efficacy and safety of CGP 56697 (artemether and benflumetol) compared with chloroquine to treat acute falciparum malaria in Tanzanian children aged 1-5 years.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Efficacy and safety of CGP 566 ...... anian children aged 1-5 years.
@en
Efficacy and safety of CGP 56697
@nl
type
label
Efficacy and safety of CGP 566 ...... anian children aged 1-5 years.
@en
Efficacy and safety of CGP 56697
@nl
prefLabel
Efficacy and safety of CGP 566 ...... anian children aged 1-5 years.
@en
Efficacy and safety of CGP 56697
@nl
P2093
P2860
P921
P1476
Efficacy and safety of CGP 566 ...... anian children aged 1-5 years.
@en
P2093
Gathmann I
Kibatala P
Schellenberg D
P2860
P304
P356
10.1046/J.1365-3156.1998.00250.X
P577
1998-06-01T00:00:00Z